Galmed Pharmaceuticals Ltd. - SHS (GLMD)

Historical Institutional Holders from Q1 2014 to Q2 2023

All holders as of June 30, 2023
Q2 2023
Type / Class
Equity / SHS
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2023 Q2 0 $0 -$871K 0
2023 Q1 2.06M $877K -$159K $0.43 20
2022 Q4 2.41M $1.21M -$53.4K $0.50 18
2022 Q3 2.58M $801K +$15.3K $0.31 20
2022 Q2 2.51M $1.69M -$628K $0.66 18
2022 Q1 2.81M $4.46M -$1.93M $1.59 21
2021 Q4 3.87M $7.05M -$758K $1.82 22
2021 Q3 4.23M $11.8M -$1.64M $2.79 22
2021 Q2 4.81M $14.6M -$2.73M $3.04 23
2021 Q1 5.66M $19.4M -$2.07M $3.43 30
2020 Q4 6.26M $19.5M -$1.31M $3.11 21
2020 Q3 6.65M $23.4M -$4.13M $3.53 22
2020 Q2 7.42M $35.4M +$2.99M $4.78 23
2020 Q1 7.06M $24.4M +$4.27M $3.46 31
2019 Q4 5.89M $34M -$2.92M $5.78 30
2019 Q3 6.3M $30.1M -$11.3M $4.78 29
2019 Q2 7.73M $56.8M +$2.33M $7.35 32
2019 Q1 7.42M $60.6M -$1.34M $8.17 33
2018 Q4 7.65M $52.2M -$1.02M $6.83 42
2018 Q3 7.61M $103M -$17.4M $13.58 37
2018 Q2 8.33M $99.1M +$76.7M $11.90 41
2018 Q1 2.65M $14.8M -$1.3M $5.57 19
2017 Q4 2.73M $25M +$7.07M $9.15 19
2017 Q3 1.25M $11.4M +$1.87M $9.10 11
2017 Q2 1.05M $6.52M +$852K $6.20 10
2017 Q1 919K $4.49M +$227K $4.88 8
2016 Q4 894K $3.14M +$620K $3.51 11
2016 Q3 706K $3.14M +$690K $4.43 17
2016 Q2 550K $2.47M -$816K $4.48 17
2016 Q1 722K $3.56M -$484K $4.93 18
2015 Q4 779K $5.93M -$206K $7.61 20
2015 Q3 806K $5.99M -$289K $7.42 20
2015 Q2 831K $8.36M -$1.17M $10.06 22
2015 Q1 948K $8.93M +$742K $9.41 22
2014 Q4 930K $5.39M -$2.05M $5.80 16
2014 Q3 1.16M $10M -$6.3M $8.60 19
2014 Q2 1.82M $17.7M +$1.01M $9.74 20
2014 Q1 1.68M $19.3M +$19.3M $11.47 20